| Clinical data | |
|---|---|
| Other names | MPC; Medroxyprogesterone capronate; Medroxyprogesterone hexanoate; 6α-Methyl-17α-hydroxyprogesterone hexanoate; 6α-Methyl-17α-hydroxypregn-4-ene-3,20-dione hexanoate |
| Routes of administration | Intramuscular injection |
| Drug class | Progestogen;Progestin;Progestogen ester |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C28H42O4 |
| Molar mass | 442.640 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Medroxyprogesterone caproate (MPC) is aprogestin and aprogestogen ester which wassynthesized in 1958 but was never marketed.[1][2] It has been confused withhydroxyprogesterone caproate (OHPC) andmedroxyprogesterone acetate (MPA) in a number of publications.[3][4][5][6][7][8][9][10][11][12] In addition to MPA and OHPC,analogues of MPC includechlormadinone caproate,gestonorone caproate,megestrol caproate, andmethenmadinone caproate.
Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byexpanding it. |